US EditionReport Warns Drug-Resistant Superbug Infections Will Soon Soar
Researchers predict a substantial rise in drug-resistant bloodstream infections among older adults and men in Europe by 2030, based on over 12 million blood test analyses.
- On November 4, a PLOS Medicine study led by Gwenan Knight projected rising drug-resistant bloodstream infections across Europe, driven by demographic shifts.
- Demographic shifts prompted increases in resistant bloodstream infections as ageing populations, especially older age groups and the over 65s, drive higher rates, researchers found in AMR projections.
- Using more than 12 million routine blood tests, researchers analysed data from 29 European countries to generate incidence rates and predict resistant bloodstream infections.
- The study found that even with strong public-health interventions, achieving the 10% reduction target was possible for only about two-thirds of bacteria–antibiotic combinations, highlighting the need for accurate burden estimates to target interventions and track progress.
- Authors warn burdens will vary between countries, with rates rising more in men than women across six of the eight bacteria studied and increasing sharply in older age groups in the coming years.
40 Articles
40 Articles
Drug-resistant bloodstream infections expected to rise across Europe by 2030
The rates of bloodstream infections caused by drug-resistant bacteria will increase substantially across Europe in the next five years, driven largely by aging populations, according to a new paper published November 4th in the open-access journal PLOS Medicine by Gwenan Knight of the London School of Hygiene and Tropical Medicine, UK, and colleagues.
ABC FOX Montana
Report warns drug-resistant superbug infections will soon soar
The research team explained that antimicrobial resistance (AMR) is a global public health crisis.
Demographic shifts could boost drug-resistant infections across Europe
The rates of bloodstream infections caused by drug-resistant bacteria will increase substantially across Europe in the next five years, driven largely by aging populations, according to a new paper published in PLOS Medicine by Gwenan Knight of the London School of Hygiene and Tropical Medicine, UK, and colleagues.
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
